Susquehanna International Group
ENVB icon

Susquehanna International Group’s Enveric Biosciences ENVB Stock Holding History

Susquehanna International Group’s Portfolio ENVB Stock Details ENVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1
Closed -$12K – 13210
2021
Q4 		$12K Sell
1
-10
-91% -$141K ﹤0.01% 12907
2021
Q3 		$200K Buy
+11
New +$214K ﹤0.01% 11477

Other funds holding ENVB

AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Susquehanna International Group's ENVB Position: Q2 2024 in Review

Susquehanna International Group sold out of Enveric Biosciences (ENVB) in Q2 2024, closing a stake of 101 shares — an estimated $18.2K sold.

Susquehanna International Group first reported a position in ENVB in Q4 2021 and held it in 4 quarters. The position peaked at $58K in Q1 2022. 13 funds tracked by Wall St. Rank hold ENVB as of Q2 2024.

  • Susquehanna International Group reported no remaining Enveric Biosciences position as of Q2 2024 after selling out during the quarter.
  • Susquehanna International Group sold 101 Enveric Biosciences shares in Q2 2024, an estimated $18.2K.
  • Susquehanna International Group first reported a position in Enveric Biosciences in Q4 2021 and held it in 4 quarters.
  • Susquehanna International Group's Enveric Biosciences position peaked at $58K in Q1 2022.
  • 13 funds tracked by Wall St. Rank held Enveric Biosciences as of Q2 2024.

Based on Susquehanna International Group's 13F filing for Q2 2024, filed 15 Aug 2024.